BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 12036937)

  • 1. mdmx is a negative regulator of p53 activity in vivo.
    Finch RA; Donoviel DB; Potter D; Shi M; Fan A; Freed DD; Wang CY; Zambrowicz BP; Ramirez-Solis R; Sands AT; Zhang N
    Cancer Res; 2002 Jun; 62(11):3221-5. PubMed ID: 12036937
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation.
    Ghosh M; Huang K; Berberich SJ
    Biochemistry; 2003 Mar; 42(8):2291-9. PubMed ID: 12600196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The loss of mdm2 induces p53-mediated apoptosis.
    de Rozieres S; Maya R; Oren M; Lozano G
    Oncogene; 2000 Mar; 19(13):1691-7. PubMed ID: 10763826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rescue of embryonic lethality in Mdm4-null mice by loss of Trp53 suggests a nonoverlapping pathway with MDM2 to regulate p53.
    Parant J; Chavez-Reyes A; Little NA; Yan W; Reinke V; Jochemsen AG; Lozano G
    Nat Genet; 2001 Sep; 29(1):92-5. PubMed ID: 11528400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Constitutive mdmx expression during cell growth, differentiation, and DNA damage.
    Jackson MW; Berberich SJ
    DNA Cell Biol; 1999 Sep; 18(9):693-700. PubMed ID: 10492400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA damage-induced phosphorylation of MdmX at serine 367 activates p53 by targeting MdmX for Mdm2-dependent degradation.
    Okamoto K; Kashima K; Pereg Y; Ishida M; Yamazaki S; Nota A; Teunisse A; Migliorini D; Kitabayashi I; Marine JC; Prives C; Shiloh Y; Jochemsen AG; Taya Y
    Mol Cell Biol; 2005 Nov; 25(21):9608-20. PubMed ID: 16227609
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of MdmX as a therapeutic target for reactivating p53 in tumors.
    Garcia D; Warr MR; Martins CP; Brown Swigart L; Passegué E; Evan GI
    Genes Dev; 2011 Aug; 25(16):1746-57. PubMed ID: 21852537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MDMX: a novel p53-binding protein with some functional properties of MDM2.
    Shvarts A; Steegenga WT; Riteco N; van Laar T; Dekker P; Bazuine M; van Ham RC; van der Houven van Oordt W; Hateboer G; van der Eb AJ; Jochemsen AG
    EMBO J; 1996 Oct; 15(19):5349-57. PubMed ID: 8895579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis.
    Eischen CM; Roussel MF; Korsmeyer SJ; Cleveland JL
    Mol Cell Biol; 2001 Nov; 21(22):7653-62. PubMed ID: 11604501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MDMX stability is regulated by p53-induced caspase cleavage in NIH3T3 mouse fibroblasts.
    Gentiletti F; Mancini F; D'Angelo M; Sacchi A; Pontecorvi A; Jochemsen AG; Moretti F
    Oncogene; 2002 Jan; 21(6):867-77. PubMed ID: 11840332
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDM4 (MDMX) overexpression enhances stabilization of stress-induced p53 and promotes apoptosis.
    Mancini F; Gentiletti F; D'Angelo M; Giglio S; Nanni S; D'Angelo C; Farsetti A; Citro G; Sacchi A; Pontecorvi A; Moretti F
    J Biol Chem; 2004 Feb; 279(9):8169-80. PubMed ID: 14660608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of p53: a collaboration between Mdm2 and Mdmx.
    Pei D; Zhang Y; Zheng J
    Oncotarget; 2012 Mar; 3(3):228-35. PubMed ID: 22410433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a domain within MDMX-S that is responsible for its high affinity interaction with p53 and high-level expression in mammalian cells.
    Rallapalli R; Strachan G; Tuan RS; Hall DJ
    J Cell Biochem; 2003 Jun; 89(3):563-75. PubMed ID: 12761890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mdm4 (Mdmx) regulates p53-induced growth arrest and neuronal cell death during early embryonic mouse development.
    Migliorini D; Lazzerini Denchi E; Danovi D; Jochemsen A; Capillo M; Gobbi A; Helin K; Pelicci PG; Marine JC
    Mol Cell Biol; 2002 Aug; 22(15):5527-38. PubMed ID: 12101245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mdmx as an essential regulator of p53 activity.
    Marine JC; Jochemsen AG
    Biochem Biophys Res Commun; 2005 Jun; 331(3):750-60. PubMed ID: 15865931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stochastic modeling and simulation of the p53-MDM2/MDMX loop.
    Cai X; Yuan ZM
    J Comput Biol; 2009 Jul; 16(7):917-33. PubMed ID: 19580521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mdm2 and mdmX prevent ASPP1 and ASPP2 from stimulating p53 without targeting p53 for degradation.
    Bergamaschi D; Samuels Y; Zhong S; Lu X
    Oncogene; 2005 May; 24(23):3836-41. PubMed ID: 15782125
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of p21 partially rescues Mdm4 loss and uncovers an antiproliferative effect of Mdm4 on cell growth.
    Steinman HA; Sluss HK; Sands AT; Pihan G; Jones SN
    Oncogene; 2004 Jan; 23(1):303-6. PubMed ID: 14712235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MdmX inhibits Smad transactivation.
    Kadakia M; Brown TL; McGorry MM; Berberich SJ
    Oncogene; 2002 Dec; 21(57):8776-85. PubMed ID: 12483531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDMX regulation of p53 response to ribosomal stress.
    Gilkes DM; Chen L; Chen J
    EMBO J; 2006 Nov; 25(23):5614-25. PubMed ID: 17110929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.